NR1H3 and metabolic dysfunction-associated steatotic liver disease: Furthermore, a high-fat and high-fructose diet-induced NAFLD mice model study suggested LXRα pathway might be a novel therapeutic target of curcumin in NAFLD patients (Larasati et al., 2018 ▶).